The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and ...

The authors write "The Food, Drug and Cosmetic Law Section of the New York State Bar Association is delving into the changing ...

The FDA will decide later this month whether to approve a novel drug for acute pain that could offer a nonaddictive ...

After nearly a decade of machine learning innovations, the FDA has issued its first draft guidance on the use of AI in drug ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications ...

SLP highlighted its impact on the pharma industry through support of the development of a majority of the drugs approved by ...

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released ...

This could reduce the cost of Zepbound to $168 per month. Many health insurance plans don't cover the weight loss drug Zepbound because it's so new. It was approved by the FDA at the end of 2023.

“We are proud that our advanced modeling and simulation software and consulting services supported the development of every drug approved by the FDA in 2024 ... acceptance of new software and improved ...